Testing effectiveness (Phase 2)Study completedNCT04359784
What this trial is testing
Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy
Who this might be right for
B-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer Center 27